IRF4 overexpression is a hallmark of activated B-cell-like type of diffuse large B-cell lymphoma and associated with classical Hodgkin lymphoma (cHL), plasma cell myeloma and primary effusion lymphoma (Carbone et al., 2002). Here, IRF4 is linked to primary effusion lymphoma.